BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Denali Therapeutics

Denali Therapeutics logo

Founded
2015
Patents
33
Clinical Trials
14
Publications
51

Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.


Posts Mentioning This Company

Companies Driving Innovation To Fight Alzheimer’s Disease

  
The overall technological progress in medicine and the overall increase in the quality and safety of life, compared to even a century ago, led to a substantial growth of the population, and longer life expectancy for humans -- more and more people live up to their  60s, 70s, 80s and …